Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00333437
What this trial is testing

Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement

Who this might be right for
Scleroderma, Systemic
University of California, San Francisco 7
Not applicableStudy completedNCT04001556
What this trial is testing

RElevance of UltraSonography for Assessing Salivary Gland Involvement in Systemic Sclerosis (SSc)

Who this might be right for
Systemic Sclerosis
Rennes University Hospital 75
Early research (Phase 1)Study completedNCT02426229
What this trial is testing

Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma

Who this might be right for
SclerodermaInterstitial Lung Disease
Medical University of South Carolina 15
Not applicableStudy completedNCT00668473
What this trial is testing

Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
University of Michigan 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05925803
What this trial is testing

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

Who this might be right for
Systemic SclerosisScleroderma
AstraZeneca 314
Very early researchNot Yet RecruitingNCT06970951
What this trial is testing

Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusRheumatoid ArthritisDry Syndrome+2 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 15
Not applicableStudy completedNCT01697254
What this trial is testing

The CARRA Registry

Who this might be right for
Juvenile Idiopathic ArthritisSystemic Lupus ErythematosusMixed Connective Tissue Disease+9 more
Duke University 9,587
Testing effectiveness (Phase 2)Looking for participantsNCT06828042
What this trial is testing

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErthematosusSystemic Sclerosis (SSc)Sjogren Syndrome+3 more
Peking University Third Hospital 9
Post-approval studies (Phase 4)UnknownNCT04928586
What this trial is testing

Immunosuppressant Combined With Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 200
Very early researchWithdrawnNCT06866080
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech Co.
Testing effectiveness (Phase 2)Looking for participantsNCT06947460
What this trial is testing

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension+1 more
Beijing GoBroad Hospital 45
Testing effectiveness (Phase 2)Study completedNCT05214794
What this trial is testing

An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Maruho Co., Ltd. 6
Not applicableLooking for participantsNCT06732674
What this trial is testing

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

Who this might be right for
Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified ElsewhereSystemic Sclerosis PulmonaryDermatomyositis+3 more
Oslo University Hospital 218
Large-scale testing (Phase 3)Looking for participantsNCT05878717
What this trial is testing

The Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseScleroderma, Systemic
GlaxoSmithKline 300
Not applicableStudy completedNCT02975960
What this trial is testing

ADMSCs for the Treatment of Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
The Catholic University of Korea 7
Large-scale testing (Phase 3)Study completedNCT01878526
What this trial is testing

Gastroesophageal Reflux Treatment in Scleroderma

Who this might be right for
Gastroesophageal Reflux DiseaseSystemic SclerosisScleroderma
Khon Kaen University 80
Not applicableStudy completedNCT03614208
What this trial is testing

Individualized Home-based Exercise Program for Patient With Systemic Sclerosis.

Who this might be right for
Systemic Sclerosis
Universita di Verona 33
Testing effectiveness (Phase 2)Ended earlyNCT03919799
What this trial is testing

KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
System; SclerosisDiffuse Cutaneous Systemic Sclerosis
Kadmon, a Sanofi Company 36
Testing effectiveness (Phase 2)WithdrawnNCT02588625
What this trial is testing

A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Who this might be right for
Scleroderma
Bristol-Myers Squibb
Not applicableStudy completedNCT01848418
What this trial is testing

Conception of an ICF Core Set for Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris 113
Next Page